Differential elevation of TERT activity and sensitivity to temozolomide by type of TERT mutation in MGMT promoter-methylated glioblastoma

被引：0
|
作者：
Weller, Michael
Papachristodoulou, Alexandros
Hentschel, Bettina
Gramatzki, Dorothee
Felsberg, Joerg
Loeffler, Markus
Schackert, Gabriele
Westphal, Manfred
Tonn, Joerg
Silginer, Manuela
von Deimling, Andreas
Pietsch, Torsten
Reifenberger, Guido
Roth, Patrick
机构：
[1] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland
[2] Univ Leipzig, Inst Med Informat Stat & Epidemol, Leipzig, Germany
[3] Heinrich Heine Univ Hosp, Dept Neuropathol, Dusseldorf, Germany
[4] Univ Hosp Dresden, Dept Neurosurg, Dresden, Germany
[5] Univ Hamburg, Dept Neurosurg, Hamburg, Germany
[6] Univ Munich LMU, Dept Neurosurg, Munich, Germany
[7] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany
[8] Univ Bonn, Dept Neuropathol, Bonn, Germany
[9] Univ Hosp Zurich, Zurich, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2013
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DIFFERENTIAL ELEVATION OF TERT ACTIVITY AND SENSITIVITY TO TEMOZOLOMIDE BY TYPE OF TERT MUTATION IN MGMT PROMOTER-METHYLATED GLIOBLASTOMA
    Silginer, Manuela
    Papachristodolou, Alexandros
    Hentschel, Bettina
    Gramatzki, Dorothee
    Felsberg, Jorg
    Loeffler, Markus
    Schackert, Gabriele
    Westphal, Manfred
    Tonn, Jorg-Christian
    von Deimling, Andreas
    Pietsch, Torsten
    Reifenberger, Guido
    Roth, Patrick
    Weller, Michael
    NEURO-ONCOLOGY, 2018, 20 : 48 - 49
  • [2] TERT PROMOTER MUTATION AND MGMT PROMOTER METHYLATION-MEDIATED SENSITIVITY TO TEMOZOLOMIDE IN IDH-WILDTYPE GLIOBLASTOMA: IS THERE A LINK?
    Gramatzki, Dorothee
    Felsberg, Joerg
    Hentschel, Bettina
    Wolter, Marietta
    Schackert, Gabriele
    Westphal, Manfred
    Regli, Luca
    Thon, Niklas
    Tatagiba, Marcos
    Wick, Wolfgang
    Schlegel, Uwe
    Krex, Dietmar
    Matschke, Jakob
    Roth, Patrick
    Suresh, Marian
    Kamp, Marcel
    Rushing, Elisabeth
    Pietsch, Torsten
    von Deimling, Andreas
    Sabel, Michael
    Loeffler, Markus
    Weller, Michael
    Reifenberger, Guido
    NEURO-ONCOLOGY, 2020, 22 : 14 - 14
  • [3] Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
    Tunthanathip, Thara
    Sangkhathat, Surasak
    Tanvejsilp, Pimwara
    Kanjanapradit, Kanet
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2021, 12 (04) : 694 - 703
  • [4] Differential radiosensitizing potential of temozolomide in mgmt promoter methylated glioblastoma multiforme cell lines
    Van Nifterik, Krista A.
    Van den Berg, Jaap
    Stalpers, Lukas J. A.
    Lafleur, M. Vincent M.
    Leenstra, Sieger
    Slotman, Ben J.
    Hulsebos, Theo J. M.
    Sminia, Peter
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04): : 1246 - 1253
  • [5] A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma
    Wang, Wen
    Zhang, Lu
    Wang, Zheng
    Yang, Fan
    Wang, Haoyuan
    Liang, Tingyu
    Wu, Fan
    Lan, Qing
    Wang, Jiangfei
    Zhao, Jizong
    ONCOTARGET, 2016, 7 (43) : 69991 - 69999
  • [6] EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma
    Nina Struve
    Zev A. Binder
    Lucy F. Stead
    Tim Brend
    Stephen J. Bagley
    Claire Faulkner
    Leonie Ott
    Justus Müller-Goebel
    Anna-Sophie Weik
    Konstantin Hoffer
    Leonie Krug
    Thorsten Rieckmann
    Lara Bußmann
    Marvin Henze
    Jennifer J. D. Morrissette
    Kathreena M. Kurian
    Ulrich Schüller
    Cordula Petersen
    Kai Rothkamm
    Donald M. O´ Rourke
    Susan C. Short
    Malte Kriegs
    Oncogene, 2020, 39 : 3041 - 3055
  • [7] EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma
    Struve, Nina
    Binder, Zev A.
    Stead, Lucy F.
    Brend, Tim
    Bagley, Stephen J.
    Faulkner, Claire
    Ott, Leonie
    Mueller-Goebel, Justus
    Weik, Anna-Sophie
    Hoffer, Konstantin
    Krug, Leonie
    Rieckmann, Thorsten
    Bussmann, Lara
    Henze, Marvin
    Morrissette, Jennifer J. D.
    Kurian, Kathreena M.
    Schueller, Ulrich
    Petersen, Cordula
    Rothkamm, Kai
    O'Rourke, Donald M.
    Short, Susan C.
    Kriegs, Malte
    ONCOGENE, 2020, 39 (15) : 3041 - 3055
  • [8] A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients
    Cheng, Wen
    Ren, Xiufang
    Cai, Jinquan
    Zhang, Chuanbao
    Li, Mingyang
    Wang, Kuanyu
    Liu, Yang
    Han, Sheng
    Wu, Anhua
    ONCOTARGET, 2015, 6 (30) : 29285 - 29295
  • [9] Telomerase reverse transcriptase (TERT) promoter mutation and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation-mediated sensitivity to temozolomide in IDH-wildtype glioblastoma: Is there a link?
    Weller, M.
    Gramatzki, D.
    Felsberg, J.
    Hentschel, B.
    Wolter, M.
    Schackert, G.
    Westphal, M.
    Regli, L.
    Thon, N.
    Tatagiba, M.
    Wick, W.
    Schlegel, U.
    Krex, D.
    Roth, P.
    Rushing, E.
    Pietsch, T.
    von Deimling, A.
    Sabel, M.
    Loeffler, M.
    Reifenberger, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S396 - S396
  • [10] TERT Promoter Mutations Correlate with IDHs, MGMT and EGFR in Glioblastoma Multiforme
    Tomar, Manendra Singh
    Shrivastava, Ashutosh
    NEUROLOGY INDIA, 2021, 69 (01) : 135 - 136
12345